Department of Psychiatry, University of Münster, Germany.
Hum Brain Mapp. 2014 Jul;35(7):2995-3007. doi: 10.1002/hbm.22380. Epub 2013 Sep 13.
Bipolar disorder and Major depressive disorder are difficult to differentiate during depressive episodes, motivating research for differentiating neurobiological markers. Dysfunctional amygdala responsiveness during emotion processing has been implicated in both disorders, but the important rapid and automatic stages of emotion processing in the amygdala have so far never been investigated in bipolar patients.
fMRI data of 22 bipolar depressed patients (BD), 22 matched unipolar depressed patients (MDD), and 22 healthy controls (HC) were obtained during processing of subliminal sad, happy and neutral faces. Amygdala responsiveness was investigated using standard univariate analyses as well as pattern-recognition techniques to differentiate the two clinical groups. Furthermore, medication effects on amygdala responsiveness were explored.
All subjects were unaware of the emotional faces. Univariate analysis revealed a significant group × emotion interaction within the left amygdala. Amygdala responsiveness to sad>neutral faces was increased in MDD relative to BD. In contrast, responsiveness to happy>neutral faces showed the opposite pattern, with higher amygdala activity in BD than in MDD. Most of the activation patterns in both clinical groups differed significantly from activation patterns of HC--and therefore represent abnormalities. Furthermore, pattern classification on amygdala activation to sad>happy faces yielded almost 80% accuracy differentiating MDD and BD patients. Medication had no significant effect on these findings.
Distinct amygdala excitability during automatic stages of the processing of emotional faces may reflect differential pathophysiological processes in BD versus MDD depression, potentially representing diagnosis-specific neural markers mostly unaffected by current psychotropic medication.
在抑郁发作期间,双相情感障碍和重度抑郁症很难区分,这促使人们研究区分神经生物学标志物。情绪处理过程中杏仁核反应功能障碍与这两种疾病都有关,但迄今为止,人们从未研究过双相情感障碍患者的杏仁核在情绪处理中快速和自动的阶段。
在处理潜意识悲伤、快乐和中性面孔期间,获得了 22 名双相抑郁患者(BD)、22 名匹配的单相抑郁患者(MDD)和 22 名健康对照者(HC)的 fMRI 数据。使用标准的单变量分析以及模式识别技术来研究杏仁核反应,以区分这两个临床组。此外,还探讨了药物对杏仁核反应的影响。
所有受试者都没有察觉到情绪面孔。单变量分析显示,左杏仁核存在显著的组×情绪交互作用。与 BD 相比,MDD 对悲伤>中性面孔的杏仁核反应增强。相比之下,对快乐>中性面孔的反应则呈现相反的模式,BD 的杏仁核活性高于 MDD。两个临床组的大部分激活模式与 HC 的激活模式明显不同,因此代表异常。此外,对悲伤>快乐面孔的杏仁核激活进行模式分类,能够以近 80%的准确率区分 MDD 和 BD 患者。这些发现不受药物的影响。
在情绪面孔处理的自动阶段,杏仁核的兴奋性不同可能反映了 BD 与 MDD 抑郁的不同病理生理过程,可能代表了受当前精神药物影响较小的、具有诊断特异性的神经标记物。